HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
TerminatedEUCTR 2013-002386-18

Network connectivity and inhibitory control under atomoxetin challenge - A pharamacological "resting state" and "inhibitory task" fMRI study in patients with ADHD

This historical record does not confirm current site availability.

Historical research recordGermany
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Who could participate?

This study is for people with ADHD. Other eligibility criteria apply.

Listed locations
Germany
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Terminated
Enrollment listed in the registry
Not clearly listed
Sponsor
RWTH Aachen Clinical Trials Center Aachen (CTC-A)
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Germany
Age range
Not clearly listed
Official registry ID
EUCTR 2013-002386-18
Official title
Show the full official title

Network connectivity and inhibitory control under atomoxetin challenge - A pharamacological "resting state" and "inhibitory task" fMRI study in patients with ADHD

Recruitment & locations

Terminated

Germany

Checked Official study record (opens in a new tab)
Registry details
Historical country statuses

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is RWTH Aachen Clinical Trials Center Aachen (CTC-A).

Who can participate?

This study is for people with ADHD. Other eligibility criteria apply.

Is this study still recruiting?

The historical registry lists this study as terminated.

Want to explore more studies?

Explore studies